MOSANOS owner Contact Information online
from Amgen Inc.
MOSANOS
US serial number:85132591
Application filling date:Sep. 17, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Dec. 16, 2013
Publication date:Mar. 15, 2011
Abandoned date:Dec. 16, 2013
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for use in the treatment of oncological diseases and disorders, and complications associated therewith
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:Pharmaceutical preparations for use in the treatment of oncological diseases and disorders
and complications associated therewith
Current owner owner name:Amgen Inc.
Current owner owner address:One Amgen Center Drive
Thousand Oaks,
CALIFORNIA
UNITED STATES
913201799
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Mark Sommers
Attorney email:docketing@finnegan.com
Attorney docket number:12157.0001
Attorney email authorized:Yes
Correspondent name address:Mark Sommers
Finnegan, Henderson, Farabow, Garrett & Dunner, LL
901 New York Avenue, N.W.
Washington,
DISTRICT OF COLUMBIA
UNITED STATES
20001
Correspondent phone:202.408.4000
Correspondent email:docketing@finnegan.com
Correspondent fax:202.408.4400
Correspondent email authorized:Yes
Trademark staff tm attorney:BELL, MARLENE D
Trademark staff law office assigned MOSANOS:LAW OFFICE 105
Latest trademarks
Popular owners
Glaxo Group Limited (174) JOHNSON & JOHNSON (136) Novartis AG (134) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (47) Bayer Aktiengesellschaft (44) SANOFI (43) Pfizer Inc. (41) Wyeth LLC (41) Bristol-Myers Squibb Company (35) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) S. C. Johnson & Son, Inc. (29) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 15, 2011 Mar. 08, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Sep. 21, 2010 Jan. 25, 2011 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
